Cumulative consumption of tea is associated with lower risk of liver cancer: updated results from the Shanghai Women's Health Study

Zhuo‐Ying Li,Yu‐Ting Tan,Da‐Ke Liu,Li‐Feng Gao,Hong‐Lan Li,Yong‐Bing Xiang
DOI: https://doi.org/10.1002/ijc.34310
2022-10-06
International Journal of Cancer
Abstract:Prospective epidemiological studies have provided limited evidence for an association between tea consumption and liver cancer risk. Based on a population‐based prospective cohort study in middle‐aged Chinese women, we investigated the association between tea consumption and the risk of primary liver cancer. Detailed information on tea drinking habits and other potential confounders was obtained at the baseline interview. Incident liver cancer cases were identified through record linkage with the population‐based cancer registry and verified through home visits and review of medical charts by medical experts. Multiple aspects of tea drinking habits including starting age, duration, intensity, and cumulative consumption of any type of tea and green tea were considered. Multivariable‐adjusted hazard ratios (aHRs) and their 95% confidence intervals (CIs) were derived from the Cox regression models. After a median follow‐up time of 18.12 (interquartile range=1.59) years, 253 incident liver cancer cases were identified from 71,841 cohort members. Compared to never tea drinkers, the risk of liver cancer for participants who have consumed over 30 kg of dried tea leaves cumulatively was 0.56 (95% CI: 0.32‐0.97). For those who drank green tea only, the aHR was 0.54 (95% CI: 0.30‐0.98). This updated study suggested an inverse association between cumulative consumption of tea, especially green tea, and the risk of primary liver cancer.
oncology
What problem does this paper attempt to address?